title: Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome.
authors.affiliation: University Department of Medicine and Haematology, Aarhus Amtssygehus, Denmark.
authors.forename: P D
authors.initials: PD
authors.lastname: Jensen
authors.forename: I M
authors.initials: IM
authors.lastname: Jensen
authors.forename: J
authors.initials: J
authors.lastname: Ellegaard
mesh_terms: D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D003676:Deferoxamine / Q000627:therapeutic use*; D004909:Erythrocyte Indices; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*; D010976:Platelet Count; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D003676:Deferoxamine